Evaluation of in vitro PXR-based assays and in silico modeling approaches for understanding the binding of a structurally diverse set of drugs to PXR
Authors:
- Elliott NickbargENElliott Nickbarg
- Wenyan WangWWWenyan Wang
- Ann ThomasATAnn Thomas
- Michael ZiebellMZMichael Ziebell
- Winfred W. ProsiseWPWinfred W. Prosise
- Charles A. LesburgCLCharles A. Lesburg
- S. Shane TaremiSTS. Shane Taremi
- Valerie L. GerlachVGValerie L. Gerlach
- Hung V. LeHLHung V. Le
- K.-C. ChengKCK.-C. Cheng
- 1 March 2011
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 81 (5) , 669-679
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Application and interpretation of hPXR screening data: Validation of reporter signal requirements for prediction of clinically relevant CYP3A4 inducersBiochemical Pharmacology, 2008
- Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stabilityProtein Engineering, Design and Selection, 2008
- Quantitative PCR assay for cytochromes P450 2B and 3A induction in rat precision-cut liver slices: Correlation study with induction in vivoJournal of Pharmacological and Toxicological Methods, 2005
- Coactivator Binding Promotes the Specific Interaction Between Ligand and the Pregnane X ReceptorJournal of Molecular Biology, 2003
- Pxr, car and drug metabolismNature Reviews Drug Discovery, 2002
- A Cell-Based Reporter Gene Assay for Determining Induction of CYP3A4 in a High-Volume SystemThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptorsProceedings of the National Academy of Sciences, 2001
- Use of the nuclear receptor PXR to predict drug interactionsToxicology, 2000
- Pharmacogenomics: Translating Functional Genomics into Rational TherapeuticsScience, 1999
- An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling PathwayCell, 1998